Donor lymphocyte infusions for acute myeloid leukaemia.

Abstract

The success of donor lymphocyte infusion (DLI) in treating chronic myeloid leukaemia that had recurred after allogeneic haematopoietic stem cell transplantation provided direct evidence for the existence of an immunologically mediated graft-vs-leukaemia effect and led to the development of non-myeloablative transplantation. For patients with acute myeloid… (More)
DOI: 10.1016/j.beha.2008.07.009

Topics

  • Presentations referencing similar topics